Quickly
Socially
Trending
CryptoSERUM INSTITUTE OF INDIA
Arvind Kejriwal Allows RT-PCR COVID-19 Tests Without Prescription In Delhi, Vaccine ‘Sputnik V’ To Be Tested In India, Says Russian Media
COVID-19 Vaccine Update: Clinical Trials of Oxford's Covishield Will Continue in India, Says Serum Institute of India After AstraZeneca Puts Trials on Hold in UK
COVID-19 Vaccine Update: Indian-Origin Professor Sumi Biswas’ UK Firm, SpyBiotech, Strikes Pact With India
COVID-19 Vaccine: ‘Covishield’ To Be Available In 73 Days? Serum Institute Of India Busts Fake News, Calls Such Reports False
COVID-19 Vaccines in India Update: Bharat Biotech, Zydus Cadila in Phase 2 Trials, Oxford Candidate in Phase 3
COVID-19 Vaccine Update: Serum Institute's Vaccine ‘Covishield’ Administered to 2 of 5 Volunteers at Pune's Bharati Hospital After 3 of Them Showed Antibodies
COVID-19 Vaccine Update: Phase 2 Human Trial of Oxford University Vaccine May Start Tomorrow at Bharati Vidyapeeth Medical College in Pune
COVID-19 Vaccine 'Covishield' to be Available in 73 Days? Serum Institute of India Calls Media Reports False and Conjectural
COVID-19 Vaccine Update: Serum Institute of India Initiates Phase 2, 3 Clinical Study of 'Covishield' on 1,600 Volunteers
COVID-19 Vaccine Update: 'Covishield' of Oxford-Astrazeneca and Serum Institute Possibly India's 1st Shot, Release Likely by 2020-End
Coronavirus Vaccines, Developed by Oxford University And Novavax, to Cost Around Rs 225 in India, SII Fixes Rate at $3 Per Dose
COVID-19 Vaccine: Serum Institute of India Enters into New Partnership With Bill And Melinda Gates Foundation, Others, to Accelerate Manufacturing & Delivery of 100 Million Doses of Coronavirus Vaccine
COVID-19 Vaccine Update: DCGI Nod to Serum Institute of India for Phase 2 and 3 Human Clinical Trials of Oxford University Vaccine Candidate
COVID-19 Vaccine Update: DCGI Nod to Serum-Oxford Coronavirus Vaccine for Phase 2, 3 Clinical Trials in India
Coronavirus Vaccine Update: DCGI Asks Serum Institute to Revise Protocol For Phase 2, 3 Trials of Oxford COVID-19 Vaccine
Google Trends
Live Bot